COVID-19: combining antiviral and anti-inflammatory treatments
Clicks: 348
ID: 266552
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
348 views
48 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #6 of 8 articles by views in The Lancet. Infectious Diseases
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
COVID-19: combining antiviral and anti-inflammatory treatments
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (6 words).
Try re-searching for a better abstract.
| Reference Key |
j2020thecovid-19:
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Stebbing J;Phelan A;Griffin I;Tucker C;Oechsle O;Smith D;Richardson P;; |
| Journal | The Lancet. Infectious Diseases |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
covid-19
sars-cov-2
pubmed abstract
nih
national institutes of health
national library of medicine
pandemics
Viral
comment
pneumonia
betacoronavirus
anti-inflammatory agents
coronavirus infections / drug therapy
antiviral agents*
peter richardson
justin stebbing
pmid:32113509
pmc7158903
doi:10.1016/s1473-3099(20)30132-8
anne phelan
azetidines
sulfonamides
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.